Level 1 of 6Core
Malaria: recognition, severity and parenteral treatment
The core to-do list — diagnose and manage, at a glance
Diagnose— recognise it
- Ask the one question that makes the diagnosis: does the patient live in, has recently left, or has travelled through a malarious area — malaria cannot be diagnosed clinically. The WHO regards fever a week or more after entering a malaria risk area, and up to three months after departure, as a medical emergency — and chemoprophylaxis taken faithfully never excludes malaria. Falciparum typically presents 7–28 days after exposure; vivax and ovale may declare themselves more than a year later.
- Send a thick and a thin film plus a rapid diagnostic test: the thick film detects, the thin film speciates and quantifies — "malaria parasites seen" without species and percentage is not a usable result. A single negative film does not exclude malaria: repeat thick films at 12–24 hours and on days 1 and 2 (at least three films), and treat on clinical grounds if confirmation will be delayed and the patient is unwell.
- Check a bedside glucose in every case and repeat it: blood glucose below 2.2 mmol/L is a severity criterion, a perfect imitator of cerebral malaria, and it recurs after correction.
- Define severe malaria at the bedside, not from the count — any one of: impaired consciousness or coma; prostration (unable to sit or stand unaided, a child unable to feed or drink); two or more generalised seizures in 24 hours; glucose below 2.2 mmol/L; pH below 7.3 with deep sighing respiration; systolic below 80 mmHg in an adult (below 70 in a young child); pulmonary oedema or ARDS; PCV below 15% or haemoglobin below 50 g/L; spontaneous bleeding or DIC; oliguria with creatinine rising above about 265 µmol/L; black or cola-coloured urine; jaundice (bilirubin above about 50 µmol/L) plus another organ dysfunction; hyperparasitaemia — assume severe above 1–2% in a non-immune patient.
- Read the danger signs that are easy to mislabel: deep acidotic breathing mistaken for "chest infection", a temperature below 36°C, cold peripheries with a preserved blood pressure, any convulsion, dark urine, any bleeding — and in a neonate, any abnormality at all. Genuine meningism means another diagnosis until proved otherwise; rash and lymphadenopathy point to dengue, rickettsial infection, enteric fever or acute HIV instead.
- Check the full blood count and think of co-infection: mild thrombocytopenia is usual and a normal platelet count should make you question the diagnosis; bacterial sepsis is clinically indistinguishable and about 6% of children with severe malaria are bacteraemic — the sickest patients frequently have both.
Manage now— do this, in order
- Decide severity first, because it determines the route of the drug: oral therapy for uncomplicated disease, immediate parenteral therapy for severe disease and for any patient unable to swallow; if the species is uncertain, treat as falciparum.
- IV artesunate is the treatment of choice for all severe malaria, in all age groups and in every trimester of pregnancy: 2.4 mg/kg IV at 0, 12 and 24 hours, then once daily; children under 20 kg get 3 mg/kg per dose on the same schedule — the commonest dosing error is giving the small child the adult 2.4 mg/kg. Check the weight before drawing up.Doctor / Nurse
- Reconstitute artesunate correctly: 60 mg dried powder with the supplied ampoule of 5% sodium bicarbonate, shaken until completely clear, diluted to about 10 mg/mL with 5% dextrose or 0.9% sodium chloride for IV use (about 20 mg/mL for IM), given as a slow bolus over 1–2 minutes — discard any solution that remains cloudy.Doctor / Nurse
- No artesunate — quinine dihydrochloride IV: loading dose 20 mg/kg of quinine salt (max 1.4 g) over 4 hours, then 10 mg/kg (max 700 mg) over 4 hours 8-hourly for 48 hours, then 12-hourly; omit the loading dose and give 10 mg/kg instead if quinine, quinidine or mefloquine has been received within 24 hours; monitor the ECG continuously, and measure glucose every 4–6 hours with co-administered 5–10% dextrose — quinine causes hyperinsulinaemic hypoglycaemia, a genuine cause of death, especially in pregnancy.Doctor / Nurse
- Continue parenteral treatment for at least 24 hours regardless of improvement, then complete a full three-day course of an oral ACT (or oral artesunate 2 mg/kg daily to a cumulative 17–18 mg/kg). Parenteral artesunate alone does not cure malaria; never use an artemisinin as monotherapy, and never use mefloquine as follow-on (post-malaria neurological syndrome).
- Correct hypoglycaemia and recheck: adult 50 mL of 50% glucose IV, or 100–200 mL of 10% glucose, then a 10% infusion; child 2 mL/kg of 10% glucose IV or IO (neonate 2.5 mL/kg), then a 10% infusion. 25% or 50% glucose must not be given peripherally in a child, and never treat the coma without first excluding hypoglycaemia.
- Coma and convulsions: maintain the airway, nurse on the side (aspiration pneumonia is a recognised and lethal complication), exclude hypoglycaemia and bacterial meningitis, intubate if the airway cannot be protected; treat convulsions promptly with IV or rectal diazepam (paraldehyde where unavailable). Fluids are a drug with a dose and a toxicity: 250–500 mL over 15 minutes in a hypotensive adult, 10 mL/kg over 10–20 minutes in a child, reassessing after each — restrict fluid the moment urea or creatinine rises despite adequate rehydration.Doctor / Nurse
- Severe anaemia: transfuse fresh whole blood or packed cells (10 mL/kg in children); a PCV below 15% is the widely used threshold where blood is short. Pulmonary oedema: nurse at 45 degrees, oxygen, stop IV fluids, give a diuretic; CPAP or intubation with PEEP for life-threatening hypoxaemia.Doctor / NurseNot available at your setup — Blood & blood products.
- Give empirical antibacterial therapy alongside the antimalarial in every child with severe malaria in an endemic area (covering non-typhoidal *Salmonella* from the outset), every adult with parasitaemia above 20%, every patient with shock, and any severely ill patient who fails to respond — ideally with blood cultures in all severe malaria. Never give the four harmful ancillary treatments: glucocorticoids, prophylactic phenobarbitone, heparin and adrenaline.Doctor / NurseNot available at your setup — Blood culture.
Parenteral treatment of severe malaria
| Drug / route | Adult | Child |
|---|---|---|
| Artesunate IV (first line) | 2.4 mg/kg at 0, 12, 24 h then daily | ≥ 20 kg as adult; < 20 kg 3 mg/kg per dose |
| Artesunate IM (no access) | 2.4 mg/kg same schedule | < 20 kg 3 mg/kg |
| Quinine dihydrochloride IV | Load 20 mg/kg salt (max 1.4 g) over 4 h, then 10 mg/kg (max 700 mg) 8-hourly ×48 h, then 12-hourly | Same mg/kg; pair with clindamycin |
| Rectal artesunate (pre-referral only) | 10 mg/kg single dose, then transfer | 10 mg/kg |
Refer / escalate
Any patient meeting a single WHO severe-malaria criterion, any non-immune patient with a parasitaemia above 1–2%, any patient unable to swallow, any pregnant woman, any child under five with prostration or convulsion, and any neonate with any abnormality needs immediate parenteral artesunate and urgent referral — give the first artesunate dose (or rectal artesunate 10 mg/kg if nothing else is available) before transfer, never after.
Read the full lesson free
Create a free account to unlock every page, the level exams, and progress tracking.
Sign up freeLog in